S&CO Inc. Sells 12,592 Shares of Humana Inc. (NYSE:HUM)

S&CO Inc. decreased its stake in Humana Inc. (NYSE:HUM - Free Report) by 37.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,168 shares of the insurance provider's stock after selling 12,592 shares during the quarter. S&CO Inc.'s holdings in Humana were worth $5,370,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. FPC Investment Advisory Inc. bought a new stake in shares of Humana in the fourth quarter worth about $27,000. Centricity Wealth Management LLC bought a new stake in shares of Humana in the fourth quarter worth about $30,000. Ashton Thomas Securities LLC bought a new stake in shares of Humana in the third quarter worth about $31,000. OFI Invest Asset Management bought a new stake in shares of Humana in the fourth quarter worth about $33,000. Finally, Atwood & Palmer Inc. increased its holdings in shares of Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after acquiring an additional 60 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent analyst reports. Piper Sandler increased their price target on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Barclays increased their price objective on Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a report on Thursday, February 13th. JPMorgan Chase & Co. decreased their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Finally, Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Twenty investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Humana currently has a consensus rating of "Hold" and a consensus target price of $285.68.

Remove Ads

Humana Stock Performance

Shares of HUM traded down $1.04 during mid-day trading on Tuesday, reaching $250.21. The company's stock had a trading volume of 1,387,813 shares, compared to its average volume of 1,676,635. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The stock has a market cap of $30.19 billion, a P/E ratio of 25.15, a PEG ratio of 2.05 and a beta of 0.57. The business has a 50-day simple moving average of $271.67 and a two-hundred day simple moving average of $281.65. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.41%. Humana's dividend payout ratio is presently 35.58%.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.32% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.